Abecma, Breyanzi, CARVYKTI, Kymriah, Tecartus, Yeskarta
Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso
Nhanganyaya Munzvimbo yeoncology, immunotherapy yabuda senzira yekutanga, ichishandisa immune system yemuviri kurwisa mapundu akaipa. Kune akawanda immunotherapeutic nzira, asi Chimeric Antigen Rece.
ELARA kuyedza, follicular lymphoma, Kymriah, NCT03568461, Novartis, Iyo kambani Novartis Pharmaceuticals Corporation, Tisagenlecleucel
Tisagenlecleucel inotenderwa neFDA yekudzokorora kana refractory follicular lymphoma
Chikumi 2022: Mushure memitsara miviri kana kupfuura yesystemic therapy, FDA yakapa tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) yakakurumidza kubvumidza kuvarwere vakura vane relapsed kana refractory follicular lymphoma (FL) T.
cytokine release syndrome, Jill O'Donnell-Tormey, Kymriah, Novartis
CAR-T Cell therapy inogona kuitwa yakachengeteka uye kuwanda kuwanikwa nekugadziriswa kudiki
Kurume 2022: Nzira yekushandura CAR-T Cell therapy ine mukana wekupidigura icho chave axiom yekurapa: kuti kurapwa kunoshamisa pamabundu kunouya nekurasikirwa kwenjodzi dzakakura kune murwere.
Kite, Kymriah, Novartis, Yeskarta
CAR NK kurapa ine mwero unoshanda we73%
Immunotherapy mukurapwa kwegomararaCancer CAR-NK therapy ine mwero inoshanda inosvika 73%, uye iri kutorwa mumakiriniki edzimba.Immunotherapy yakashandura nzira inorapwa nayo gomarara. Cancer immunotherapy inoparadzaniswa..
Acalabrutunib, Avelumab, CART kurapa, Dabrafanib, Kymriah, Dzazvino zvinodhaka, Midostaurin, Niraparib, Pembrolizumab, Tecartus, Tisagenlecleucel, Trametinib, USFDA
Dzazvino mishonga yekurapa kenza
Chikunguru 2021: Tarisa uone mishonga ichangoburwa mukurapa cancer. Gore rega rega, mushure mekuongorora miedzo uye zvimwe zvakakosha, USFDA inobvumidza mishonga, uye nekudaro varwere vegomarara vanogona kutenda kuti kurapwa kwave pedyo. ..